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方法：本研究利用 0.02%的 EDTA 去除失活羊膜组织的上皮细胞，并采用 IV
型胶原酶消化去除羊膜基质的纤维层及海绵层，从而获得羊膜致密层。比较从不
同位置来源的胎儿面及胎盘面羊膜，选择合适的羊膜来源。以传统的完整羊膜
（IAM）及 DAM 为对照组，探讨 UAM 的物理及生物学特性，包括光学透明度、
组织结构、脱细胞程度、超微结构，并通过对 I 型、III 型、IV 型、VII 型胶原、
Lamnin 5 及 Perlacan进行免疫荧光及组化染色分析UAM 的生物成份。此基础上，
采用 UAM 作为载体构建组织工程角膜上皮，并观察角膜上皮片的超微结构，利


















































Purpose: Amniotic membranes (AM) are widely used as a corneal epithelial tissue 
carrier in reconstruction surgery. However, the engineered tissue transparency is low 
due to the translucent thick underlying AM stroma. To overcome this drawback, we 
developed an ultra-thin AM (UAM) by stripping away from the epithelial denuded 
AM (DAM) some of the stroma, and evaluated its biomaterial characteristics and 
efficacy in corneal epithelium tissue-engineering. 
Methods: Cryo-preserved AM was treated with 0.02% EDTA and its epithelium was 
dissociated by scraper to generate DAM. Stromal side of the denuded AM (DAM) 
was then digested with type IV collagenase at 37℃ for different durations to generate 
UAM to get the compact layer of AM. AM from plancetal side and the fetal side was 
compared to choose AM with higher transparency. The characteristics including 
optical transmittance, thickness, decellularization and microstructure were evaluated. 
Intact AM (IAM) and DAM were served as control. The components of UAM were 
analyzed by immuno-straining of collagen I, III, IV, VII, perlecan and Laminin 5. 
Rabbit limbal epithelial cells were cultured on UAM and DAM to generate tissue 
engineered corneal epithelium. Cell proliferation and differentiation markers such as 
p63, ABCG2, K3, K12, K14, cell tight junction markers such as Connexin 43, 
Claudin-1, β-Catenin, Occludin, E-cadherin and anti-angiogenesis related markers 
TIMP-1 and thrombospondin-1 were detected by immunofluorescent staining, 
RT-PCR or Western blot. The microstructure was examined and photographed with 
transmission electron microscope. The engineered corneal epithelium was 
transplanted to the ocular surface of total limbal stem cells deficiency (LSCD) rabbit 
model, and the cornea was observed by slit-lamp microscope postoperatively. 
Furthermore, the corneal and limbal epithelial cell phenotype was detected by 
immunofluorescent staining postoperatively 2 weeks after animals were sacrificed. 
Results: By thinning the stroma to about 20-30μm, the UAM was rendered acellular, 
optically clear and its collagen framework became compacted and inerratic. It mainly 
















epithelial cell (RCEC) sheets generated through expansion of limbal epithelial cells 
on UAM were more transparent and thicker than those expanded on DAM, and the 
RCEC attached to the membrane more closely. Moreover, p63, ABCG2, β-catenin, 
TIMP-1 and thrombospondin-1 gene expression were greater in tissue engineered cell 
sheets expanded on UAM than those on DAM. Furthermore, 2 weeks after surgery, 
the grafted cell sheets initially grown on UAM were more stratified and transparent 
than those expanded on DAM.  
Conclusion: Taken together, tissue engineered corneal epithelium generated on UAM 
has a preferable outcome because the transplanted tissue is more transparent and 
better resembles the phenotype of the native tissue than that obtained by using DAM 
for this procedure. UAM preserves compact layer of the amniotic membrane and 
maybe an ideal substrate for corneal epithelial tissue engineering. 
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弹性的半透明光滑薄膜，它不含 HLA-A、B、C 及 DR 等抗原成分[16]。一般情况




管道系统[20]；羊膜的基底膜厚约 0.1μm，是人体最厚的基底膜，主要包含 IV 型、
VII 型胶原，Laminin 5、Perlecan、actin、α-actinin、spectrin、ezrin、vimentin、

























图 1. 羊膜的结构 
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